JP2008526937A5 - - Google Patents

Download PDF

Info

Publication number
JP2008526937A5
JP2008526937A5 JP2007550834A JP2007550834A JP2008526937A5 JP 2008526937 A5 JP2008526937 A5 JP 2008526937A5 JP 2007550834 A JP2007550834 A JP 2007550834A JP 2007550834 A JP2007550834 A JP 2007550834A JP 2008526937 A5 JP2008526937 A5 JP 2008526937A5
Authority
JP
Japan
Prior art keywords
disease
disorder
subject
treatment
sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007550834A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008526937A (ja
Filing date
Publication date
Priority claimed from GBGB0500487.4A external-priority patent/GB0500487D0/en
Application filed filed Critical
Publication of JP2008526937A publication Critical patent/JP2008526937A/ja
Publication of JP2008526937A5 publication Critical patent/JP2008526937A5/ja
Pending legal-status Critical Current

Links

JP2007550834A 2005-01-11 2006-01-10 ファクターXIIaのフォーム Pending JP2008526937A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0500487.4A GB0500487D0 (en) 2005-01-11 2005-01-11 Forms of factor XIIa
PCT/GB2006/000072 WO2006075142A2 (en) 2005-01-11 2006-01-10 FORMS OF FACTOR XIIa

Publications (2)

Publication Number Publication Date
JP2008526937A JP2008526937A (ja) 2008-07-24
JP2008526937A5 true JP2008526937A5 (https=) 2009-02-26

Family

ID=34203898

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007550834A Pending JP2008526937A (ja) 2005-01-11 2006-01-10 ファクターXIIaのフォーム

Country Status (9)

Country Link
US (1) US20080274477A1 (https=)
EP (1) EP1848799A2 (https=)
JP (1) JP2008526937A (https=)
CN (1) CN101180391A (https=)
AU (1) AU2006205700A1 (https=)
BR (1) BRPI0606307A2 (https=)
CA (1) CA2609109A1 (https=)
GB (1) GB0500487D0 (https=)
WO (1) WO2006075142A2 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0607515D0 (en) * 2006-04-13 2006-05-24 Axis Shield Diagnostics Ltd Anti-factor xlla therapy
IL230564B2 (en) 2011-07-22 2023-09-01 Csl Ltd Anticoagulant monoclonal antibodies anti–factor xii/fxiia, a method for their preparation, a pharmaceutical compound containing them and medical uses.
WO2013190041A1 (en) * 2012-06-22 2013-12-27 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and kits for predicting the survival time of post acute myocardial infarction patients
CN104345154B (zh) * 2014-08-22 2016-10-26 北京蛋白质组研究中心 一种检测多肿瘤相关“多肽-蛋白组合式标志物”的双抗体夹心试剂盒
CN104177503B (zh) * 2014-08-22 2018-04-13 北京蛋白质组研究中心 一种激酶通路相关“多肽‑蛋白组合式”标志物及定量检测技术
CN107405399B (zh) 2015-01-02 2022-02-08 武田药品工业株式会社 针对血浆激肽释放酶和因子xii的双特异性抗体
AU2016297018B9 (en) * 2015-07-21 2022-12-01 Takeda Pharmaceutical Company Limited A monoclonal antibody inhibitor of factor XIIa

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8901859D0 (en) * 1989-01-27 1989-03-15 Shield Diagnostics Limited Diagnostic test
WO2004057343A2 (en) * 2002-12-20 2004-07-08 Axis-Shield Diagnostics Limited Detection or determination of variants of factor xiia

Similar Documents

Publication Publication Date Title
IL279359B2 (en) Biomarkers and methods for diagnosing Alzheimer's and other neurodegenerative diseases
JP5337096B2 (ja) 動脈硬化の評価法
KR20100128281A (ko) 바이오마커 와이케이엘-40의 수준을 측정함으로써 발견되는 생존 예후에 따른 심혈관계 질환에 걸린 개체들의 분류 방법
JP2020500309A (ja) エキソソームの亜集団の定量および神経変性障害の診断
TW202217316A (zh) 用於偵測tau蛋白病或類澱粉蛋白生成疾病的基於血液之檢定
US11193943B2 (en) Endothelial cell derived exosomes and uses thereof
JP2003508753A (ja) 中枢神経系の損傷を検出するためのアッセイ
KR20200135947A (ko) 치매의 진단 및/또는 예측을 위한 아드레노메둘린 (adm) 및 치매의 요법 또는 예방에 사용하기 위한 항-아드레노메둘린 결합제
JP2019502933A (ja) 不安定狭心症の診断
JP2008526937A5 (https=)
JP5747315B2 (ja) 糖鎖不全ヒトIgA1ヒンジ部を認識する抗体及びその用途
US20120135431A1 (en) Type iv collagen-like immunoreactive peptide
WO2022170000A1 (en) Methods, assays and compositions for measuring brain damage or harm during surgery
EP3342861B1 (en) Specifically purified anti-presepsin antibody
JP6835332B2 (ja) 動脈硬化を検出するための血中バイオマーカー
US20060205024A1 (en) Method to diagnose and evaluate progression of Alzheimer's disease
US20220057501A1 (en) Endothelial Cell Derived Exosomes and Uses Thereof
CN117007819B (zh) 用于辅助诊断阿尔茨海默病的试剂盒
EP4553173A1 (en) Markers for detecting and monitoring liver fibrosis
JP7628320B2 (ja) 変性hdlの定量方法、及びそれに用いる分析用試薬
JP7496992B2 (ja) 動脈硬化病変の検出方法、検出試薬及び検出キット
US20220276264A1 (en) DARPin REAGENTS THAT DISTINGUISH ALZHEIMER'S DISEASE AND PARKINSON'S DISEASE SAMPLES
EP4261540A1 (en) Marker for assisting in diagnosis of nephrotic syndrome and use thereof
JP2008505053A (ja) 単離された多発性硬化症関連細胞傷害性因子、および当該細胞傷害性因子の検出方法
JPWO2009020058A1 (ja) 脱髄病変へのドラッグデリバリーシステム及び脱髄病変の生化学的マーカー